EUVIMEDEUVIMED entdecken
Crossref

Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease

Clarissa G A Alvaia, Pollyana C Leal, Mylaine S Mendonça, João E C Melo, José M M Bispo, Abraão J Barbosa, Marco A M Freire, Regina H Silva, Alessandra M Ribeiro, Katty A A L Medeiros, Auderlan M Gois, José R Santos

Pharmacology Biochemistry and Behavior · 2026-09 · 266 · 174219

DOI: 10.1016/j.pbb.2026.174219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026-09. Verfasst von Clarissa G A Alvaia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral and Evolutionary Neurobiology Laboratory, Department of Bioscience, Federal University of Sergipe, Itabaiana, SE, 49506-036, SE, Brazil. Hauptthemen laut MEDLINE: Fluoxetine, Anxiety, Selective Serotonin Reuptake Inhibitors, Parkinson Disease. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Universidade Federal de Sergipe, CAPES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized not only by the gradual loss of motor control but also by a wide range of non-motor symptoms, including anxiety and depression, which can precede motor dysfunction by years. These psychiatric manifestations are commonly managed with selective serotonin reuptake inhibitors (SSRI). However, their impact on motor function in the early stages of PD remains controversial. In this study, we investigated the effects of fluoxetine in a progressive model of parkinsonism induced by repeated low-dose reserpine in male Wistar rats. Animals received short- (four injections) or middle-term (ten injections) reserpine (0.1 mg/kg, one every 48 h) treatment combined or not with daily fluoxetine (10 mg/kg) administration, and were evaluated for catalepsy, oral movements, open field behavior, body weight, and immunoreactivity for tyrosine hydroxylase (TH) and serotonin (5-HT). Fluoxetine decreased anxiety-like behavior, assessed by reducing the time animals spend exploring the center of the apparatus; potentiated reserpine-induced motor deficits, leading to earlier onset of cataleptic immobility, enhanced oral dyskinesia, reduced exploratory activity and body weight loss. In addition, fluoxetine alone decreased TH immunoreactivity in the dorsal striatum while increasing 5-HT labeling in the dorsal raphe nucleus, suggesting serotonergic modulation of dopaminergic circuits. In conclusion, fluoxetine administration prevented anxiety-like behavior but anticipated and exacerbated the motor changes caused by reserpine. Furthermore, simultaneous treatment with fluoxetine and reserpine worsened motor and behavioral impairments irrespective of TH changes, indicating that functional disturbances may precede dopaminergic degeneration. These findings highlight that fluoxetine, while targeting mood alterations, may exacerbate motor alterations during prodromal and initial stages of parkinsonism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineAnxietySelective Serotonin Reuptake InhibitorsParkinson DiseaseMotor ActivityAnimalsMaleRats, WistarRatsReserpineDisease Models, AnimalTyrosine 3-MonooxygenaseSerotoninCatalepsyBehavior, Animal

Stichwörter der Autor:innen

Animal modelDopamineNon-motor symptomsParkinson's diseaseReserpineSerotonin

Substanzen

FluoxetineReserpineSelective Serotonin Reuptake InhibitorsTyrosine 3-MonooxygenaseSerotonin

Autor:innen und Institutionen

  • Behavioral and Evolutionary Neurobiology Laboratory, Department of Bioscience, Federal University of Sergipe, Itabaiana, SE, 49506-036, SE, Brazil.
  • Department of Pharmacology, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Department of Biosciences, Federal University of São Paulo, Santos, SP, Brazil.
  • Department of Nursing, Federal University of Sergipe, Lagarto, SE, Brazil.
  • Molecular Neurobiology Laboratory, Department of Bioscience, Federal University of Sergipe, Itabaiana, SE, 49506-036, SE, Brazil.
  • Behavioral and Evolutionary Neurobiology Laboratory, Department of Bioscience, Federal University of Sergipe, Itabaiana, SE, 49506-036, SE, Brazil. Electronic address: joseronaldosantos@academico.ufs.br.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Universidade Federal de Sergipe
  • CAPES
  • Fundação de Apoio à Pesquisa e à Inovação Tecnológica do Estado de Sergipe
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Alvaia, C. G. A., Leal, P. C., Mendonça, M. S., Melo, J. E. C., Bispo, J. M. M., Barbosa, A. J., Freire, M. A. M., Silva, R. H., Ribeiro, A. M., Medeiros, K. A. A. L., Gois, A. M., & Santos, J. R. (2026). Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease. Pharmacology Biochemistry and Behavior, 266, 174219. https://doi.org/10.1016/j.pbb.2026.174219

Vancouver

Alvaia CGA, Leal PC, Mendonça MS, Melo JEC, Bispo JMM, Barbosa AJ, et al. Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease. Pharmacology Biochemistry and Behavior. 2026;266:174219. doi:10.1016/j.pbb.2026.174219

BibTeX
@article{Alvaia2026,
  author = {Alvaia, Clarissa G A and Leal, Pollyana C and Mendonça, Mylaine S and Melo, João E C and Bispo, José M M and Barbosa, Abraão J and Freire, Marco A M and Silva, Regina H and Ribeiro, Alessandra M and Medeiros, Katty A A L and Gois, Auderlan M and Santos, José R},
  title = {Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2026},
  volume = {266},
  pages = {174219},
  doi = {10.1016/j.pbb.2026.174219}
}
Kostenlos starten →